Clemens Peter A - Insider Stock Trading - OpenInsider

CIK: 1056695 - Address: C/o Acura Pharmaceuticals, Inc., 616 N. North Court, Suite 120, Palatine, IL 60067

18 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	5	14	13	5	24	-4	-23	5
P	%wins				100	100	60	60	60	20	67
S	%ret	1	1	2	-2	-12	-20	-26	-32	-50	-24
S	%wins				100	100	100	100	100	100	100

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
11/20/23 12:07	11/20/23	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	0	0.00	0	40	8	545	D
1/5/23 16:08	1/3/23	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	0	0.00	0	40	9	505	D
8/5/22 16:16	8/3/22	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	0	0.00	0	49	12	465	D
2/26/21 16:10	2/24/21	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	6	0.1510	0	40	11	416	D
1/6/21 16:10	1/4/21	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	0	0.00	0	49	14	391	D
1/6/20 16:37	1/2/20	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	0	0.00	0	9	3	361	D
12/15/17 16:23	12/14/17	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	P	30	0.1000	0	300	544	355	D
5/16/14 10:56	5/16/14	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	P.a	4	1.21	0	3	1	280	D	-60	-50	-33	-36	-22	-18	-13	-9	8	10	-8	-23	-48	-29
5/16/14 10:48	5/16/14	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	P	4	1.21	0	3	1	280	D	-60	-50	-33	-36	-22	-18	-13	-9	8	10	-8	-23	-48	-29
3/3/14 16:03	2/27/14	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	12	1.30	0	9	4	277	D	-42	-4	32	16	9	16	4	5	-8	-12	-26	-46	-50	-55
12/19/13 12:30	12/17/13	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	12	1.30	0	9	3	331	D	-58	-39	-22	-1	-5	-8	-7	4	-1	9	15	5	-32	-70
3/21/12 16:04	3/12/12	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	S	-39	3.86	0	-10	-3	382	D	-25	38	34	9	25	28	29	20	-1	-6	-17	-21	-50	-42
1/4/12 16:28	1/1/12	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	12	1.30	0	9	2	392	D	-36	1	-9	-5	0	-7	-6	-1	-2	1	-7	-3	-7	-25
8/15/11 13:28	8/15/11	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	P.am	8	2.67	0	3	1	438	M	-55	6	-21	-40	-34	-19	-23	-13	26	23	16	54	36	-43
8/15/11 13:20	8/15/11	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	P.m	9	2.67	0	4	1	439	M	-55	6	-21	-40	-34	-19	-23	-13	26	23	16	54	36	-43
1/26/11 16:39	1/25/11	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	M.d	12	1.30	0	9	2	442	M	-39	-42	5	12	1	-18	-16	-9	2	0	7	59	6	30
1/26/11 16:39	1/26/11	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	P.d	1	2.98	0	0	0	442	M	-39	-42	5	12	1	-18	-16	-9	2	0	7	59	6	30
11/13/07 17:16	11/8/07	ACUR	Acura Pharmaceuticals, Inc	NY	Health	Drug	Pharmaceutical Preparations	Clemens Peter A	IL	O	SVP,CFO	S.m	-311	1.17	0	-265	-6	4,451	D	72	60	37	-45	-40	-43	-26	-25	-2	-18	-23	-30	-14	-58

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact